Literature DB >> 25503095

Orofacial pain and Eagle Syndrome: cues from a clinical series.

A Ciorba1, S Savini, F Morolli, M Malagò, C Bianchini, S Pelucchi, A Pastore.   

Abstract

AIM: Watt Eagle, firstly described the Elongated Stylohyoid Process Syndrome (ESPS), or Eagle Syndrome, in 1937. Since then, several authors have further studied this syndrome and some classifications have been proposed in relation to signs, symptoms and etiopathogenesis. Aim of this paper was to present the clinical features of a cohort of patients affected by Eagle syndrome that underwent surgical treatment.
METHODS: Retrospective study. A cohort of ten patients that underwent surgical intervention for Eagle syndrome from January 2000 to December 2012 has been selected. For each subject, medical history, clinical features, treatment and follow-up after surgery were evaluated. RESULTS AND
CONCLUSIONS: The surgical treatment resulted effective in 8 of 10 patients. Two patients are still complaining neck pain, although the discomfort has a lower grade and is pharmacologically controllable. Although rare, Eagle's Syndrome should be always considered in the differential diagnosis in patients with chronic orofacial pain refractory to conventional treatments.

Entities:  

Mesh:

Year:  2014        PMID: 25503095

Source DB:  PubMed          Journal:  Minerva Stomatol        ISSN: 0026-4970


  3 in total

1.  Use of an intraoperative navigation system and piezoelectric surgery for styloidectomy in a patient with Eagle's syndrome: a case report.

Authors:  Shintaro Sukegawa; Takahiro Kanno; Akio Yoshimoto; Kenichi Matsumoto; Yuka Sukegawa-Takahashi; Masanori Masui; Yoshihiko Furuki
Journal:  J Med Case Rep       Date:  2017-11-15

2.  Application of surgical navigation in styloidectomy for treating Eagle's syndrome.

Authors:  Geng Dou; Yu Zhang; Chunlin Zong; Yuanli Chen; Yuxuan Guo; Lei Tian
Journal:  Ther Clin Risk Manag       Date:  2016-04-12       Impact factor: 2.423

3.  The eagle jugular syndrome.

Authors:  Paolo Zamboni; Alba Scerrati; Erica Menegatti; Roberto Galeotti; Marcello Lapparelli; Luca Traina; Mirko Tessari; Andrea Ciorba; Pasquale De Bonis; Stefano Pelucchi
Journal:  BMC Neurol       Date:  2019-12-21       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.